Status:
COMPLETED
Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity
Lead Sponsor:
Children's Hospital Los Angeles
Conditions:
Pediatric Obesity
Meal Timing
Eligibility:
All Genders
13-19 years
Phase:
NA
Brief Summary
In adolescents, conventional obesity treatment comprehensively addresses nutritional, activity, and behavioral topics. Due to limited resources in historically marginalized communities, implementation...
Detailed Description
The prevalence of type 2 diabetes in adolescents is steadily increasing, specifically among Latino youth. Unfortunately, there is a lack of effective preventative treatments available to delay the pro...
Eligibility Criteria
Inclusion
- age 13-19 years
- Hispanic or Latino defined by the NIH as a person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race; (3)Tanner stage III and above
- (4) body mass index \> 95th percentile (5) participant must be willing and able to adhere to the assessments, visit schedules, and eating/fasting periods.
Exclusion
- diagnosis of Prader-Willi Syndrome, brain tumor or hypothalamic obesity
- serious intellectual disability
- parent/guardian-reported physical, mental of other inability to participate in the assessments
- previous bariatric surgery
- current use of an anti-obesity or other diabetes medication (e.g., phentermine, topiramate, orlistat, GLP-1 agonist, naltrexone, buproprion, or insulin)
- current participation in other interventional weight loss studies.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05391438
Start Date
September 1 2022
End Date
August 1 2023
Last Update
October 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027